About Renocrit 10000 iu
Recombinant Human Erythropoietin Injection IP 10000 IU has garnered favorable reviews among healthcare professionals for its superb efficacy in treating anemia associated with chronic renal failure, chemotherapy, and HIV therapy. This potent biotechnology-derived biologic, often remarked upon for its consistent results, comes in a clear to slightly opalescent solution and contains no preservatives. Patients and prescribers appreciate the bargain value, especially with international brand equivalents like Eprex, Epogen, and Neorecormon. Administered subcutaneously or intravenously, with a strength of 10000 IU/ml, it delivers potent stimulation of erythropoiesis and is suitable for adults and children under strict medical supervision.
Advantage, Usage & Applications of Recombinant Human Erythropoietin Injection
This injectable medication provides a potent solution for patients with anemia due to chronic kidney disease or chemotherapy. Its advantage lies in its rapid erythropoiesis stimulation, leading to improved hemoglobin levels. Administered subcutaneously or intravenously, the injection is suitable for both adults and pediatric patients. Supplied as a clear or slightly opalescent solution in a preservative-free vial, its versatility supports varied medical needs. Physicians have remarked on its efficacy, contributing to favorable treatment outcomes across different patient demographics.
Delivery Time, Export Markets & Supply Ability Information
Recombinant Human Erythropoietin Injection IP 10000 IU is dispatched swiftly, with delivery time depending on quotation details and export documentation. Main export markets include Asia, Africa, and the Middle East, meeting global demand efficiently. An accurate estimate on availability and shipment can be provided upon request, with suppliers maintaining robust stock for ongoing supply. The product is shipped securely in temperature-controlled packaging, ensuring medicine integrity until arrival at your destination.
FAQ's of Recombinant Human Erthropoietin Injection IP 10000 IU:
Q: How should Recombinant Human Erythropoietin Injection IP 10000 IU be administered?
A: This injection is administered either subcutaneously or intravenously, as directed by a physician. The dosage and frequency depend on the patient's condition and response to treatment.
Q: What conditions does this injection treat?
A: It is mainly indicated for anemia associated with chronic renal failure, chemotherapy, or HIV therapy, helping to increase red blood cell production.
Q: When can I expect delivery after placing an order?
A: Delivery time varies by location and order size. Once the quotation is confirmed, an estimated dispatch date will be provided by the supplier.
Q: Where should this injection be stored?
A: Keep the injection vials refrigerated at 2C to 8C, and do not freeze the solution. Follow all storage instructions carefully to maintain product effectiveness.
Q: What are the potential side effects of using Recombinant Human Erythropoietin Injection?
A: Possible adverse effects include hypertension, headaches, joint pain, and injection site reactions. It should not be used by those with uncontrolled hypertension or hypersensitivity to mammalian cell-derived products.